Skip to main content
Erschienen in: Acta Diabetologica 8/2017

02.06.2017 | Original Article

Elevated 1-h post-challenge plasma glucose levels in subjects with normal glucose tolerance or impaired glucose tolerance are associated with whole blood viscosity

verfasst von: Maria Adelaide Marini, Teresa Vanessa Fiorentino, Francesco Andreozzi, Gaia Chiara Mannino, Maria Perticone, Angela Sciacqua, Francesco Perticone, Giorgio Sesti

Erschienen in: Acta Diabetologica | Ausgabe 8/2017

Einloggen, um Zugang zu erhalten

Abstract

Aim

It has been suggested that glucose levels ≥155 mg/dl at 1-h during an oral glucose tolerance test (OGTT) may predict development of type 2 diabetes and cardiovascular events among adults with normal glucose tolerance (NGT 1 h-high). Studies showed a link between increased blood viscosity and type 2 diabetes. However, whether blood viscosity is associated with dysglycemic conditions such as NGT 1 h-high, impaired glucose tolerance (IGT) or impaired fasting glucose (IFG) is unsettled.

Methods

1723 non-diabetic adults underwent biochemical evaluation and OGTT. A validated formula based on hematocrit and total plasma proteins was employed to estimate whole blood viscosity. Subjects were categorized into NGT with 1 h glucose <155 mg/dL (NGT-1 h-low), NGT-1 h-high, IFG and/or IGT.

Results

Hematocrit and blood viscosity values appeared significantly higher in individuals with NGT 1 h-high, IFG and/or IGT as compared to NGT 1 h-low subjects. Blood viscosity was significantly correlated with age, waist circumference, blood pressure, HbA1c, fasting, 1- and 2-h post-challenge insulin levels, total cholesterol and low-density lipoprotein, triglycerides, fibrinogen, white blood cell, and inversely correlated with high-density lipoprotein and insulin sensitivity. Of the four glycemic parameters, 1-h post-challenge glucose showed the strongest correlation with blood viscosity (β = 0.158, P < 0.0001) in a multivariate regression analysis model including several atherosclerosis risk factors.

Conclusions

Our results demonstrate a positive relationship between blood viscosity and 1-h post-challenge plasma glucose. They also suggest that a subgroup of NGT individuals with 1-h post-challenge plasma >155 mg/dl have increased blood viscosity comparable to that observed in subjects with IFG and/or IGT.
Literatur
1.
Zurück zum Zitat Ciuffetti G, Schillaci G, Lombardini R, Pirro M, Vaudo G, Mannarino E (2005) Prognostic impact of low-shear whole blood viscosity in hypertensive men. Eur J Clin Invest 35:93–98CrossRefPubMed Ciuffetti G, Schillaci G, Lombardini R, Pirro M, Vaudo G, Mannarino E (2005) Prognostic impact of low-shear whole blood viscosity in hypertensive men. Eur J Clin Invest 35:93–98CrossRefPubMed
2.
Zurück zum Zitat Rillaerts E, van Gaal L, Xiang DZ, Vansant G, De Leeuw I (1989) Blood viscosity in human obesity: relation to glucose tolerance and insulin status. Int J Obes 13:739–745PubMed Rillaerts E, van Gaal L, Xiang DZ, Vansant G, De Leeuw I (1989) Blood viscosity in human obesity: relation to glucose tolerance and insulin status. Int J Obes 13:739–745PubMed
3.
Zurück zum Zitat Sloop GD, Garber DW (1997) The effects of low-density lipoprotein and high-density lipoprotein on blood viscosity correlate with their association with risk of atherosclerosis in humans. Clin Sci 92:473–479CrossRefPubMed Sloop GD, Garber DW (1997) The effects of low-density lipoprotein and high-density lipoprotein on blood viscosity correlate with their association with risk of atherosclerosis in humans. Clin Sci 92:473–479CrossRefPubMed
4.
Zurück zum Zitat Ernst E (1995) Haemorheological consequences of chronic cigarette smoking. J Cardiovasc Risk 2:435–439CrossRefPubMed Ernst E (1995) Haemorheological consequences of chronic cigarette smoking. J Cardiovasc Risk 2:435–439CrossRefPubMed
5.
Zurück zum Zitat Letcher RL, Chien S, Pickering TG, Laragh JH (1983) Elevated blood viscosity in patients with borderline essential hypertension. Hypertension 5:757–762CrossRefPubMed Letcher RL, Chien S, Pickering TG, Laragh JH (1983) Elevated blood viscosity in patients with borderline essential hypertension. Hypertension 5:757–762CrossRefPubMed
6.
Zurück zum Zitat Irace C, Carallo C, Scavelli F, De Franceschi MS, Esposito T, Gnasso A (2014) Blood viscosity in subjects with normoglycemia and prediabetes. Diabetes Care 37:488–492CrossRefPubMed Irace C, Carallo C, Scavelli F, De Franceschi MS, Esposito T, Gnasso A (2014) Blood viscosity in subjects with normoglycemia and prediabetes. Diabetes Care 37:488–492CrossRefPubMed
7.
Zurück zum Zitat Devereux RB, Drayer JIM, Chien S et al (1984) Whole blood viscosity as a determinant of cardiac hypertrophy in systemic hypertension. Am J Cardiol 54:592–595CrossRefPubMed Devereux RB, Drayer JIM, Chien S et al (1984) Whole blood viscosity as a determinant of cardiac hypertrophy in systemic hypertension. Am J Cardiol 54:592–595CrossRefPubMed
8.
Zurück zum Zitat Zannad F, Voisin P, Brunotte F, Bruntz JF, Stoltz JF, Gilgenkrantz JM (1988) Haemorheological abnormalities in arterial hypertension and their relation to cardiac hypertrophy. J Hypertens 6:293–297CrossRefPubMed Zannad F, Voisin P, Brunotte F, Bruntz JF, Stoltz JF, Gilgenkrantz JM (1988) Haemorheological abnormalities in arterial hypertension and their relation to cardiac hypertrophy. J Hypertens 6:293–297CrossRefPubMed
9.
Zurück zum Zitat Lee AJ, Mowbray PI, Lowe GD, Rumley A, Fowkes FG, Allan PL (1998) Blood viscosity and elevated carotid intima-media thickness in men and women: the Edinburgh Artery study. Circulation 97:1467–1473CrossRefPubMed Lee AJ, Mowbray PI, Lowe GD, Rumley A, Fowkes FG, Allan PL (1998) Blood viscosity and elevated carotid intima-media thickness in men and women: the Edinburgh Artery study. Circulation 97:1467–1473CrossRefPubMed
10.
Zurück zum Zitat Zhao HY, Li J, Xu M et al (2015) Elevated whole blood viscosity is associated with insulin resistance and non-alcoholic fatty liver. Clin Endocrinol 83:806–811CrossRef Zhao HY, Li J, Xu M et al (2015) Elevated whole blood viscosity is associated with insulin resistance and non-alcoholic fatty liver. Clin Endocrinol 83:806–811CrossRef
11.
Zurück zum Zitat Tripolino C, Irace C, Carallo C et al (2016) Association between blood viscosity and common carotid artery elasticity. Clin Hemorheol Microcirc 62:55–62CrossRefPubMed Tripolino C, Irace C, Carallo C et al (2016) Association between blood viscosity and common carotid artery elasticity. Clin Hemorheol Microcirc 62:55–62CrossRefPubMed
12.
Zurück zum Zitat Tohgi H, Yamanouchi H, Murakami M, Kameyama M (1978) Importance of the hematocrit as a risk factor in cerebral infarction. Stroke 9:369–374CrossRefPubMed Tohgi H, Yamanouchi H, Murakami M, Kameyama M (1978) Importance of the hematocrit as a risk factor in cerebral infarction. Stroke 9:369–374CrossRefPubMed
13.
Zurück zum Zitat Neumann FJ, Katus HA, Hoberg E (1991) Increased plasma viscosity and erythrocyte aggregation: indicators of an unfavourable clinical outcome in patients with unstable angina pectoris. Br Heart J 66:425–430CrossRefPubMedPubMedCentral Neumann FJ, Katus HA, Hoberg E (1991) Increased plasma viscosity and erythrocyte aggregation: indicators of an unfavourable clinical outcome in patients with unstable angina pectoris. Br Heart J 66:425–430CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Yarnell JWG, Baker IA, Sweetnam PM et al (1991) Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation 83:836–844CrossRefPubMed Yarnell JWG, Baker IA, Sweetnam PM et al (1991) Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation 83:836–844CrossRefPubMed
15.
Zurück zum Zitat Lowe G, Lee A, Rumley A, Price J, Fowkes F (1997) Blood viscosity and risk of cardiovascular events: the Edinburgh Artery study. Br J Haematol 96:168–173CrossRefPubMed Lowe G, Lee A, Rumley A, Price J, Fowkes F (1997) Blood viscosity and risk of cardiovascular events: the Edinburgh Artery study. Br J Haematol 96:168–173CrossRefPubMed
16.
Zurück zum Zitat Høieggen A, Fossum E, Moan A, Enger E, Kjeldsen SE (1998) Whole-blood viscosity and the insulin-resistance syndrome. J Hypertens 16:203–210CrossRefPubMed Høieggen A, Fossum E, Moan A, Enger E, Kjeldsen SE (1998) Whole-blood viscosity and the insulin-resistance syndrome. J Hypertens 16:203–210CrossRefPubMed
17.
Zurück zum Zitat Nordby G, Moan A, Kjeldsen SE, Os I (1995) Relationship between hemorheological factors and insulin sensitivity in normotensive and hypertensive premenopausal women. Am J Hypertens 8:439–444CrossRefPubMed Nordby G, Moan A, Kjeldsen SE, Os I (1995) Relationship between hemorheological factors and insulin sensitivity in normotensive and hypertensive premenopausal women. Am J Hypertens 8:439–444CrossRefPubMed
18.
Zurück zum Zitat Catalano C, Muscelli E, Natali A et al (1997) Reciprocal association between insulin sensitivity and the haematocrit in man. Eur J Clin Invest 27:634–637CrossRefPubMed Catalano C, Muscelli E, Natali A et al (1997) Reciprocal association between insulin sensitivity and the haematocrit in man. Eur J Clin Invest 27:634–637CrossRefPubMed
19.
Zurück zum Zitat Facchini FS, Carantoni M, Jeppesen J, Reaven GM (1998) Hematocrit and hemoglobin are independently related to insulin resistance and compensatory hyperinsulinemia in healthy, non-obese men and women. Metabolism 47:831–835CrossRefPubMed Facchini FS, Carantoni M, Jeppesen J, Reaven GM (1998) Hematocrit and hemoglobin are independently related to insulin resistance and compensatory hyperinsulinemia in healthy, non-obese men and women. Metabolism 47:831–835CrossRefPubMed
20.
Zurück zum Zitat Hanley AJ, Retnakaran R, Qi Y et al (2009) Association of hematological parameters with insulin resistance and beta-cell dysfunction in nondiabetic subjects. J Clin Endocrinol Metab 94:3824–3832CrossRefPubMed Hanley AJ, Retnakaran R, Qi Y et al (2009) Association of hematological parameters with insulin resistance and beta-cell dysfunction in nondiabetic subjects. J Clin Endocrinol Metab 94:3824–3832CrossRefPubMed
21.
Zurück zum Zitat Medalie JH, Papier CM, Goldbourt U, Herman JB (1975) Major factors in the development of diabetes mellitus in 10,000 men. Arch Intern Med 135:811–817CrossRefPubMed Medalie JH, Papier CM, Goldbourt U, Herman JB (1975) Major factors in the development of diabetes mellitus in 10,000 men. Arch Intern Med 135:811–817CrossRefPubMed
22.
Zurück zum Zitat Wannamethee SG, Perry IJ, Shaper AG (1996) Hematocrit and risk of NIDDM. Diabetes 45:576–579CrossRefPubMed Wannamethee SG, Perry IJ, Shaper AG (1996) Hematocrit and risk of NIDDM. Diabetes 45:576–579CrossRefPubMed
23.
Zurück zum Zitat Nakanishi N, Suzuki K, Tatara K (2004) Haematocrit and risk of development of type 2 diabetes mellitus in middle-aged Japanese men. Diabet Med 21:476–482CrossRefPubMed Nakanishi N, Suzuki K, Tatara K (2004) Haematocrit and risk of development of type 2 diabetes mellitus in middle-aged Japanese men. Diabet Med 21:476–482CrossRefPubMed
24.
Zurück zum Zitat Tulloch-ReidMK Hanson RL, Saremi A, Looker HC, Williams DE, Krakoff J, Knowler WC (2004) Hematocrit and the incidence of type 2 diabetes in the Pima Indians. Diabetes Care 27:2245–2246CrossRef Tulloch-ReidMK Hanson RL, Saremi A, Looker HC, Williams DE, Krakoff J, Knowler WC (2004) Hematocrit and the incidence of type 2 diabetes in the Pima Indians. Diabetes Care 27:2245–2246CrossRef
25.
Zurück zum Zitat Tamariz LJ, Young JH, Pankow JS et al (2008) Blood viscosity and hematocrit as risk factors for type 2 diabetes mellitus: the atherosclerosis risk in communities (ARIC) study. Am J Epidemiol 168:1153–1160CrossRefPubMedPubMedCentral Tamariz LJ, Young JH, Pankow JS et al (2008) Blood viscosity and hematocrit as risk factors for type 2 diabetes mellitus: the atherosclerosis risk in communities (ARIC) study. Am J Epidemiol 168:1153–1160CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Capoğlu I, Unüvar N, Bektaş Y, Yilmaz O, Kaya MD (2002) The effects of high haematocrit levels on glucose metabolism disorders. J Int Med Res 30:433–437CrossRefPubMed Capoğlu I, Unüvar N, Bektaş Y, Yilmaz O, Kaya MD (2002) The effects of high haematocrit levels on glucose metabolism disorders. J Int Med Res 30:433–437CrossRefPubMed
27.
Zurück zum Zitat Richards RS, Nwose EU (2010) Blood viscosity at different stages of diabetes pathogenesis. Br J Biomed Sci 67(2):67–70CrossRefPubMed Richards RS, Nwose EU (2010) Blood viscosity at different stages of diabetes pathogenesis. Br J Biomed Sci 67(2):67–70CrossRefPubMed
28.
Zurück zum Zitat Abdul-Ghani MA, Abdul-Ghani T, Ali N, Defronzo RA (2008) One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes. Diabetes Care 31:1650–1655CrossRefPubMedPubMedCentral Abdul-Ghani MA, Abdul-Ghani T, Ali N, Defronzo RA (2008) One-hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes. Diabetes Care 31:1650–1655CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Abdul-Ghani MA, Lyssenko V, Tuomi T, DeFronzo RA, Groop L (2009) Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia study. Diabetes Care 32:281–286CrossRefPubMedPubMedCentral Abdul-Ghani MA, Lyssenko V, Tuomi T, DeFronzo RA, Groop L (2009) Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia study. Diabetes Care 32:281–286CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Fiorentino TV, Marini MA, Andreozzi F et al (2015) One-hour postload hyperglycemia is a stronger predictor of type 2 diabetes than impaired fasting glucose. J Clin Endocrinol Metab 100:3744–3751CrossRefPubMed Fiorentino TV, Marini MA, Andreozzi F et al (2015) One-hour postload hyperglycemia is a stronger predictor of type 2 diabetes than impaired fasting glucose. J Clin Endocrinol Metab 100:3744–3751CrossRefPubMed
31.
Zurück zum Zitat Jagannathan R, Sevick MA, Fink D et al (2016) The 1-h post-load glucose level is more effective than HbA1c for screening dysglycemia. Acta Diabetol 53:543–550CrossRefPubMed Jagannathan R, Sevick MA, Fink D et al (2016) The 1-h post-load glucose level is more effective than HbA1c for screening dysglycemia. Acta Diabetol 53:543–550CrossRefPubMed
32.
Zurück zum Zitat Marini MA, Succurro E, Frontoni S et al (2012) Insulin sensitivity, β-cell function, and incretin effect in individuals with elevated 1-h postload plasma glucose levels. Diabetes Care 35:868–872CrossRefPubMedPubMedCentral Marini MA, Succurro E, Frontoni S et al (2012) Insulin sensitivity, β-cell function, and incretin effect in individuals with elevated 1-h postload plasma glucose levels. Diabetes Care 35:868–872CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Andreozzi F, Mannino GC, Perticone M, Perticone F, Sesti G (2017) Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with a pro-atherogenic lipid profile. Atherosclerosis 256:15–20CrossRefPubMed Andreozzi F, Mannino GC, Perticone M, Perticone F, Sesti G (2017) Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with a pro-atherogenic lipid profile. Atherosclerosis 256:15–20CrossRefPubMed
34.
Zurück zum Zitat Fiorentino TV, Andreozzi F, Mannino GC et al (2016) One-hour postload hyperglycemia confers higher risk of hepatic steatosis to HbA1c-defined prediabetic subjects. J Clin Endocrinol Metab 101:4030–4038CrossRefPubMed Fiorentino TV, Andreozzi F, Mannino GC et al (2016) One-hour postload hyperglycemia confers higher risk of hepatic steatosis to HbA1c-defined prediabetic subjects. J Clin Endocrinol Metab 101:4030–4038CrossRefPubMed
35.
Zurück zum Zitat Succurro E, Marini MA, Arturi F et al (2009) Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis. Atherosclerosis 207:245–249CrossRefPubMed Succurro E, Marini MA, Arturi F et al (2009) Elevated one-hour post-load plasma glucose levels identifies subjects with normal glucose tolerance but early carotid atherosclerosis. Atherosclerosis 207:245–249CrossRefPubMed
36.
Zurück zum Zitat Sciacqua A, Maio R, Miceli S et al (2012) Association between one-hour post-load plasma glucose levels and vascular stiffness in essential hypertension. PLoS ONE 7:e44470CrossRefPubMedPubMedCentral Sciacqua A, Maio R, Miceli S et al (2012) Association between one-hour post-load plasma glucose levels and vascular stiffness in essential hypertension. PLoS ONE 7:e44470CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Sciacqua A, Miceli S, Carullo G et al (2011) One-hour postload plasma glucose levels and left ventricular mass in hypertensive patients. Diabetes Care 34:1406–1411CrossRefPubMedPubMedCentral Sciacqua A, Miceli S, Carullo G et al (2011) One-hour postload plasma glucose levels and left ventricular mass in hypertensive patients. Diabetes Care 34:1406–1411CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Perticone M, Tassone EJ, Scarpino PE et al (2016) Sympathovagal balance and 1-h postload plasma glucose in normoglucose tolerant hypertensive patients. Acta Diabetol 53:41–47CrossRefPubMed Perticone M, Tassone EJ, Scarpino PE et al (2016) Sympathovagal balance and 1-h postload plasma glucose in normoglucose tolerant hypertensive patients. Acta Diabetol 53:41–47CrossRefPubMed
39.
Zurück zum Zitat de Simone G, Devereux RB, Chien S, Alderman MH, Atlas SA, Laragh JH (1990) Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults. Circulation 81:107–117CrossRefPubMed de Simone G, Devereux RB, Chien S, Alderman MH, Atlas SA, Laragh JH (1990) Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults. Circulation 81:107–117CrossRefPubMed
40.
Zurück zum Zitat Matsuda M, De Fronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470CrossRefPubMed Matsuda M, De Fronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22:1462–1470CrossRefPubMed
41.
Zurück zum Zitat Manco M, Panunzi S, Macfarlane DP et al (2010) One-hour plasma glucose identifies insulin resistance and beta-cell dysfunction in individuals with normal glucose tolerance: cross-sectional data from the relationship between insulin sensitivity and cardiovascular risk (RISC) study. Diabetes Care 33:2090–2097CrossRefPubMedPubMedCentral Manco M, Panunzi S, Macfarlane DP et al (2010) One-hour plasma glucose identifies insulin resistance and beta-cell dysfunction in individuals with normal glucose tolerance: cross-sectional data from the relationship between insulin sensitivity and cardiovascular risk (RISC) study. Diabetes Care 33:2090–2097CrossRefPubMedPubMedCentral
42.
Zurück zum Zitat Sesti G, Fiorentino TV, Succurro E et al (2014) Elevated 1-hour post-load plasma glucose levels in subjects with normal glucose tolerance are associated with unfavorable inflammatory profile. Acta Diabetol 51:927–932CrossRefPubMed Sesti G, Fiorentino TV, Succurro E et al (2014) Elevated 1-hour post-load plasma glucose levels in subjects with normal glucose tolerance are associated with unfavorable inflammatory profile. Acta Diabetol 51:927–932CrossRefPubMed
43.
Zurück zum Zitat Duncan BB, Schmidt MI, Pankow JS et al (2003) Low-grade systemic inflammation and the development of type 2 diabetes. The arteriosclerosis risk in communities study. Diabetes 52:1799–1805CrossRefPubMed Duncan BB, Schmidt MI, Pankow JS et al (2003) Low-grade systemic inflammation and the development of type 2 diabetes. The arteriosclerosis risk in communities study. Diabetes 52:1799–1805CrossRefPubMed
44.
Zurück zum Zitat Cavalot F, Petrelli A, Traversa M et al (2006) Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga diabetes study. J Clin Endocrinol Metab 91:813–819CrossRefPubMed Cavalot F, Petrelli A, Traversa M et al (2006) Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga diabetes study. J Clin Endocrinol Metab 91:813–819CrossRefPubMed
45.
Zurück zum Zitat Bergman M, Chetrit A, Roth J, Dankner R (2016) One-hour post-load plasma glucose level during the OGTT predicts mortality: observations from the Israel study of glucose intolerance, obesity and hypertension. Diabet Med 33:1060–1066CrossRefPubMed Bergman M, Chetrit A, Roth J, Dankner R (2016) One-hour post-load plasma glucose level during the OGTT predicts mortality: observations from the Israel study of glucose intolerance, obesity and hypertension. Diabet Med 33:1060–1066CrossRefPubMed
Metadaten
Titel
Elevated 1-h post-challenge plasma glucose levels in subjects with normal glucose tolerance or impaired glucose tolerance are associated with whole blood viscosity
verfasst von
Maria Adelaide Marini
Teresa Vanessa Fiorentino
Francesco Andreozzi
Gaia Chiara Mannino
Maria Perticone
Angela Sciacqua
Francesco Perticone
Giorgio Sesti
Publikationsdatum
02.06.2017
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 8/2017
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-017-1004-z

Weitere Artikel der Ausgabe 8/2017

Acta Diabetologica 8/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.